Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $154.9900 (-2.23%) ($154.3400 - $158.3200) on Sun. Apr. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.39% (three month average) | RSI | 44 | Latest Price | $154.9900(-2.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting ABBV price | ABBV will decline at least -0.695% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.695% (StdDev 1.39%) | Hourly BBV | 0 () | Intraday Trend | -1.5% | | | |
|
Resistance Level | $162.93 | 5 Day Moving Average | $157.18(-1.39%) | 10 Day Moving Average | $161.57(-4.07%) | 20 Day Moving Average | $162.93(-4.87%) | To recent high | -11.4% | To recent low | 17.3% | Market Cap | $N/A | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |